Immune Globulin Subcutaneous 16.5% in Treatment of Primary Immunodeficiency: A Two-Year, Multi-Center Analysis

Authors
Category Primary study
JournalJournal of Allergy and Clinical Immunology
Year 2024
This article has no abstract
Epistemonikos ID: 8e634d390f01b095a5d4adb0a5c76fdf0e2db534
First added on: Feb 17, 2025